Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 CAD | -0.96% | +7.25% | -23.33% |
04-17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
04-17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.33% | 107M | |
+64.82% | 62.59B | |
-1.04% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.35% | 26.21B | |
-21.53% | 19.09B | |
+5.37% | 13.08B | |
+25.60% | 12.26B | |
+28.34% | 12.05B |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- NervGen Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022